Programmed cell death 1 (PD-1) is an important target for immune checkpoint inhibitor therapies that block its signaling and boost T-cell activity. PD-1 inhibitors have been approved for treating various types of cancer.
from News Medical Medical Research News Feed https://ift.tt/QRJu4CS
0 Comments